National Comprehensive Cancer Network



About NCCN

Ovarian Cancer Panel - Disclosures as of 11/1/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Ronald D. Alvarez, MD

Morphotek Inc.;
Merrimack;
Pfizer Inc.

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
GlaxoSmithKline;
Jannsen Pharmaceutica Products, LP;
Advaris;
Vermillion

None

None

8/27/2014

Deborah K. Armstrong, MD

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
Astellas;
clovis;
Merrimack;
quintiles

Morphotek Inc.

None

None

10/15/2014

Jamie N. Bakkum-Gamez, MD

None

None

None

None

10/4/2014

Kian Behbakht, MD

None

None

None

None

8/2/2014

Marian Birkeland, PhD

None

None

None

None

10/7/2014

Jennifer Burns

None

None

None

None

9/24/2014

Lee-may Chen, MD

None

Genentech, Inc.

None

None

8/28/2014

Larry Copeland, MD

Gynecologic Oncology Group;
Teasro

Endocyte;
Oxigene

None

None

7/20/2014

Marta Ann Crispens, MD

AstraZeneca Pharmaceuticals LP;
Novartis Pharmaceuticals Corporation;
Merrimack Pharmaceuticals;
Spirogen

None

None

None

5/5/2014

Oliver Dorigo, MD, PhD

None

None

None

None

8/28/2014

Mary Dwyer, MS

None

None

None

None

10/9/2014

Fayna Ferkle, PharmD

None

None

None

None

10/14/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/4/2014

David M. Gershenson, MD

GlaxoSmithKline;
National Cancer Institute;
Pfizer Inc.

None

Johnson & Johnson;
Elsevier;
Informa;
Proctor and Gamble;
Up to Date

National Cancer Institute

7/30/2014

Heidi J. Gray, MD

None

None

None

None

8/29/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

Rachel Grisham, MD

None

Amgen Inc.

None

None

10/21/2014

Ardeshir Hakam, MD

None

None

None

None

5/1/2014

Laura J. Havrilesky, MD

None

None

None

None

10/21/2014

Miranda Hughes, PhD

None

None

None

None

4/21/2014

Carolyn Johnston, MD

None

Michigan Cancer Consortium

None

american cancer society;
american cancer society document reviewer;
external advisor/mentor for gyn oncology fellowship in Ethiopia;
michigan cancer consortium;
MPRO

9/24/2014

Shashikant Lele, MD

None

None

None

None

10/21/2014

Lainie Martin, MD

None

Clovis Oncology

None

None

2/4/2014

Ursula A. Matulonis, MD

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
GlaxoSmithKline;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation

Merck & Co., Inc.;
Acetylon

None

None

10/14/2014

Joan S. McClure, MS

None

None

None

None

6/20/2014

Robert J. Morgan, MD, FACP

NIH-CTEP

None

None

None

10/20/2014

David M. O'Malley, MD

Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
Ajinomoto Inc.;
Array Biopharma;
Clovis;
EMD Serono;
Immunogen;
Regeneron;
VEntiRx

Clovis

None

None

9/1/2014

Richard T. Penson, MD, MRCP

Amgen Inc.;
AstraZeneca Pharmaceuticals LP;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
ImClone Systems Incorporated;
Endocyte Inc.

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.

None

None

9/2/2014

Steven C. Plaxe, MD, FACOG, FACS

Amgen Inc.;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
azaya;
endocyte;
Tesaro;
Pfizer Inc.

None

Abbott Laboratories;
Bristol-Myers Squibb Company;
Pfizer Inc.

insys

8/20/2014

Donna Powell, MS, CMD, RT(T)

None

None

None

None

10/1/2014

Matthew A. Powell, MD

Bristol-Myers Squibb Company;
Eisai Inc.

AnorMED Inc.;
Genentech, Inc.

None

None

10/8/2014

Elena Ratner, MD

       

Pending

Steven W. Remmenga, MD

None

None

None

None

5/2/2014

Paul Sabbatini, MD

Prim Biomed

None

None

None

3/22/2014

Joseph T. Santoso, MD

None

Jannsen Pharmaceutica Products, LP;
lab cor;
vermillion

None

None

1/20/2014

Theresa L. Werner, MD

None

None

None

None

5/2/2014